Physician

Andrew Thomas Voglewede, M.D.

According to 2025 Medicare claims, Andrew Voglewede, M.D. (NPI: 1699905315) practices otolaryngology, with the plurality of this provider's patient population coming from Watauga, NC. This provider's primary affiliated billing organization is BLUE RIDGE EAR, NOSE AND THROAT, INC. (NPI: 1285846493; TIN: 561946315) and primary practice location at 28607-4862.

Voglewede's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 605 traditional Medicare patients, billed 3,651 HCPCS/CPT codes, and received $133,621 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,900 prescription claims across 438 beneficiaries totaling $219,527 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 45 claims. Open Payments data shows 12 records totaling $257. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $53,007 to $219,527. In contrast, DME billing represents a smaller volume and rose steadily, from $601 to $3,414.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	779	6,802	$184,778
2016	815	7,563	$191,768
2017	739	5,950	$155,830
2018	816	6,243	$179,522
2019	942	7,054	$188,949
2020	767	7,767	$170,884
2021	783	7,115	$204,660
2022	791	7,397	$197,222
2023	737	6,725	$180,493
2024	605	3,651	$133,621

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	405	1,357	$53,007
2016	462	2,125	$94,334
2017	386	1,796	$77,672
2018	479	1,993	$211,270
2019	551	2,180	$245,951
2020	500	2,205	$235,786
2021	504	1,959	$168,627
2022	556	2,203	$193,471
2023	540	2,166	$236,283
2024	438	1,900	$219,527

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	24	$671
2020	N/R	62	$1,722
2021	N/R	24	$1,118
2022	N/R	N/R	N/R
2023	N/R	37	$1,342
2024	N/R	45	$2,012

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	296	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	133	156	$63
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	74	86	$39
69210	Removal of impacted ear wax	188	225	$31
95117	Professional service for multiple injections of allergen	83	430	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	19	532	$71,884
Dupixent Pen	Dupilumab	11	364	$49,917
Xolair	Omalizumab	12	336	$33,536
Azelastine Hcl	Azelastine Hcl	188	8,040	$8,280
Breo Ellipta	Fluticasone/Vilanterol	11	570	$7,321

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4629	Tracheostomy care kit for established tracheostomy	N	N/R	12	$1,643
A4623	Tracheostomy, inner cannula	N	N/R	11	$280
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	N	N/R	11	$46
A7007	Large volume nebulizer, disposable, unfilled, used with aerosol compressor	N	N/R	11	$43

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$257	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Thomas Voglewede, M.D.?

Tedicare shows public-source Medicare data for Andrew Thomas Voglewede, M.D. (NPI 1699905315), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Thomas Voglewede, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Thomas Voglewede, M.D.?

Andrew Thomas Voglewede, M.D. is linked to BLUE RIDGE EAR, NOSE AND THROAT, INC. (billing NPI 1285846493) in the available physician profile data.

Does Andrew Thomas Voglewede, M.D. have Open Payments data?

Andrew Thomas Voglewede, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.